- Conditions
- Acute Leukemia, Leukemia
- Interventions
- TRIAL Web-Based Application
- Behavioral
- Lead sponsor
- Dana-Farber Cancer Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Condition Directory
Leukemia clinical trials
Directory of U.S. ClinicalTrials.gov public records for Leukemia. Browse Leukemia recruiting trials, filter by phase, sponsor, location, or intervention, and open the official ClinicalTrials.gov study record for each result.
By the Clinical Trials Finder editorial team Guidance last reviewed June 10, 2026 Data synced May 21, 2026 Report an issue
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
731
Shown on this page
12
Local recruiting
41
Local phase groups
6
How Leukemia studies are organized in the registry
“Leukemia” is an umbrella term; in practice most records name the specific subtype, and this directory has dedicated pages for the major ones — acute myeloid (AML), chronic lymphocytic (CLL), and acute lymphoblastic (ALL) leukemia. Use this page when scanning across subtypes, and the subtype pages when you know which disease you mean.
- 6% of the 731 locally indexed Leukemia records are currently marked recruiting.
- The most common phase group in the local index is Phase 2 (360 records).
- The most frequent sponsor is M.D. Anderson Cancer Center (83 records).
- The most listed study location is Houston, Texas (175 records).
Terms that often appear in related listings
These describe how studies tend to be titled and grouped on ClinicalTrials.gov — they are search vocabulary, not medical guidance.
Showing 1–12 of 731 matching trials for Leukemia.
Indexed local directory records.
Phase distribution
Phase 2 360
Phase 1 241
Phase 3 61
Not applicable 59
Early Phase 1 5
Phase 4 2
Top locations
Top sponsors
Top therapies
Indexed official records
Open in full search- Conditions
- Central Nervous System Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Leukemia, Lymphoma, Plasma Cell Myeloma, Secondary Central Nervous System Lymphoma
- Interventions
- Magnetic Resonance Imaging, Neurocognitive Assessment, Quality-of-Life Assessment, Questionnaire Administration
- Procedure · Other
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Leukemia
- Interventions
- Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Inotuzumab ozogamicin, Mercaptopurine, Methotrexate, Pegfilgrastim, Prednisone, Rituximab, Vincristine
- Drug
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 1 Year to 25 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2029
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Leukemia, Lymphoma
- Interventions
- Not listed
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Eligibility
- 5 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2028
- U.S. locations
- 3
- States / cities
- Los Angeles, California • Bethesda, Maryland • Seattle, Washington
- Conditions
- Hematological Malignancy, Leukemia, Lymphoid Leukemia, Monocytic Leukemia, Multiple Myeloma, Myeloid Leukemia, Non-hodgkin Lymphoma, Other Hematologic Condition
- Interventions
- Behavioral Coaching Intervention, Virtual Exercise Platform
- Behavioral
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2033
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Juvenile Myelomonocytic Leukemia, Leukemia, Minimal Residual Disease, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Acute Undifferentiated Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Lymphoblastic Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm, Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive, Refractory Myelodysplastic Syndrome
- Interventions
- Biospecimen Collection, Bone Marrow Aspiration, CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- Procedure · Biological
- Lead sponsor
- Fred Hutchinson Cancer Center
- Other
- Eligibility
- Up to 80 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2028
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Graft-versus-host Disease, Hodgkin Lymphoma, Leukemia, Lymphoma, Myelodysplastic Syndromes, Non-hodgkin Lymphoma
- Interventions
- Busulfan, Clofarabine, Cord Blood Units, Cyclophosphamide, Cyclosporine, Fludarabine, Mycophenolate Mofetil, Tacrolimus, Thiotepa, Total Body Irradiation
- Drug · Biological · Radiation
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- Up to 26 Years
- Enrollment
- 71 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Biphenotypic Acute Leukemia, Burkitt Leukemia, Burkitt Lymphoma, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia With Crisis of Blast Cells, Chronic Myelogenous Leukemia, Accelerated Phase, Leukemia, Lymphoblastic Lymphoma, Lymphoma After Relapse, Myelodysplasia, Other Malignant Hematologic Diseases in Remission
- Interventions
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- Device
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 0 Years to 25 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2032
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Anal Cancer, Bile Duct Cancer, Bladder Cancer, Breast Cancer, Central Nervous System Cancer, Central Nervous System Tumor, Colon Cancer, Duodenal Cancer, Endometrial Cancer, Esophageal Cancer, Familial Adenomatous Polyposis, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, Healthy Control, Hypopharyngeal Cancer, Kidney Cancer, Laryngeal Cancer, Leukemia, Lip Cancer, Liver Cancer, Lung Cancer, Lynch Syndrome, Melanoma, Mesothelioma, Multiple Myeloma, Nasal Cavity Cancer, Nasopharyngeal Cancer, Neuroendocrine Tumors, Oral Cavity Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Paranasal Sinus Cancer, Penile Cancer, Peritoneal Surface Malignancies, Plasma Cell Dyscrasia, Prostate Cancer, Rectal Cancer, Salivary Gland Cancer, Sarcoma, Skin Cancer, Small Intestine Cancer, Testicular Cancer, Thymus Cancer, Thyroid Cancer, Unknown Primary Tumor, Ureter Cancer, Urethral Cancer, Vaginal Cancer
- Interventions
- Not listed
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 19 Years to 110 Years
- Enrollment
- 999,999 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2099
- U.S. locations
- 42
- States / cities
- Greenwood Village, Colorado • Manchester, Connecticut • Daytona Beach, Florida + 34 more
- Conditions
- Leukemia
- Interventions
- Chemotherapy, Placebo, Quizartinib
- Drug
- Lead sponsor
- Daiichi Sankyo
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 700 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 53
- States / cities
- Goodyear, Arizona • Phoenix, Arizona • Tucson, Arizona + 44 more
- Conditions
- Leukemia
- Interventions
- Allopurinol, Obinutuzumab, Pirtobrutinib, Valacyclovir, Venetoclax
- Drug
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Blood Cancer, Hematologic Malignancy, Leukemia, Lymphoma, Multiple Myeloma
- Interventions
- Palliative Care, Usual Care
- Behavioral
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
About this Leukemia clinical trials directory page
- What this page lists
- U.S. ClinicalTrials.gov public records that list Leukemia as a study condition, including recruiting, not yet recruiting, and active not recruiting trials across phase 1, phase 2, and phase 3.
- How to narrow results
- Use the filters above to scope by intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, age, or NCT ID within Leukemia.
- Where the data comes from
- Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, ranking of trials by quality, or AI-generated medical summaries.
Related: all condition pages, browse by drug or therapy, browse by U.S. city, browse by sponsor, or open the full search for Leukemia.